FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
06/13/2025
Back to search
Official data from USPTO
FEPVILD
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
04/03/2026
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
06/21/2023
Registration date
12/17/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/17/2024
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
DE
Examiner
BRECKENFELD, WILLIAM G
Law office
M70
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Boehringer Ingelheim International GmbH
Representatives
Max Moskowitz OSTROLENK FABER LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism; pharmaceutical preparations for the prevention and treatment of diseases and disorders and of the blood and blood forming organs; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; pharmaceutical preparations for the treatment and prevention of infectious diseases and disorders and viral infections; pharmaceutical preparations for the prevention and treatment of oncological and auto-immune diseases and disorders; pharmaceutical preparations, namely, cell based immune therapeutics for treatment of cancer, for treatment of immunological diseases, and treatment of infectious diseases
Publications
History of USPTO decisions and trademark events.
26 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/27/2025
FIMP
FINAL DISPOSITION PROCESSED
05/27/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/17/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
01/24/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/08/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
01/08/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/17/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
12/17/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/29/2024
PUBO
PUBLISHED FOR OPPOSITION
10/29/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/09/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/23/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/20/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/20/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/20/2024
RFNT
REFUSAL PROCESSED BY IB
04/16/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/22/2024
RFRR
REFUSAL PROCESSED BY MPU
03/22/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/02/2024
CNRT
NON-FINAL ACTION WRITTEN
03/01/2024
DOCK
ASSIGNED TO EXAMINER
02/29/2024
MAFR
APPLICATION FILING RECEIPT MAILED
09/01/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/28/2023
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
08/18/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/10/2023
Continuous trademark protection
Get notified about every new filing that threatens FEPVILD or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.